Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bold

Showing results (31-40 of 183) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|July 17, 2003
AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2B N Fahy, M Schlieman, S Virudachalam, et al.
Medical Care|November 9, 2023
Optimal Definition of Pancreaticoduodenectomy in the International Classification of Diseases, 10th Revision, Procedure Coding SystemGarth H Utter, Ganesh Rajasekar, Miriam Nuño, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 16, 2014
Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancerRouzbeh Daylami, Diego J Muilenburg, Subbulakshmi Virudachalam, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 31, 2002
Modern parathyroid surgery: a cost-benefit analysis of localizing strategiesBridget N Fahy, Richard J Bold, Laurel Beckett, et al.
Magnesium Research|March 1, 1994
In vitro relationship between magnesium and insulin secretionJ Ishizuka, R J Bold, C M Townsend, et al.
Journal of Cellular Physiology|October 1, 1995
Secretin potentiates cholecystokinin-stimulated amylase release by AR4-2J cells via a stimulation of phospholipase CR J Bold, J Ishizuka, C M Townsend, et al.
Anticancer Research|February 11, 2014
Role of autophagy in apoptotic regulation by Akt in pancreatic cancerDiego Muilenburg, Colin Parsons, Jodi Coates, et al.
JAMA Surgery|May 23, 2014
Outcomes of pancreaticoduodenectomy: where should we focus our efforts on improving outcomes?Erin G Brown, Anthony Yang, Robert J Canter, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2004
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell lineMelinda M Mortenson, Michael G Schlieman, Subbulakshmi Virudachalam, et al.
Pancreas|March 1, 1996
All-trans-retinoic acid inhibits growth of human pancreatic cancer cell linesR J Bold, J Ishizuka, C M Townsend, et al.
Pageof 19

Showing results (31-40 of 183) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|July 17, 2003
AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2B N Fahy, M Schlieman, S Virudachalam, et al.
Medical Care|November 9, 2023
Optimal Definition of Pancreaticoduodenectomy in the International Classification of Diseases, 10th Revision, Procedure Coding SystemGarth H Utter, Ganesh Rajasekar, Miriam Nuño, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 16, 2014
Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancerRouzbeh Daylami, Diego J Muilenburg, Subbulakshmi Virudachalam, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 31, 2002
Modern parathyroid surgery: a cost-benefit analysis of localizing strategiesBridget N Fahy, Richard J Bold, Laurel Beckett, et al.
Magnesium Research|March 1, 1994
In vitro relationship between magnesium and insulin secretionJ Ishizuka, R J Bold, C M Townsend, et al.
Journal of Cellular Physiology|October 1, 1995
Secretin potentiates cholecystokinin-stimulated amylase release by AR4-2J cells via a stimulation of phospholipase CR J Bold, J Ishizuka, C M Townsend, et al.
Anticancer Research|February 11, 2014
Role of autophagy in apoptotic regulation by Akt in pancreatic cancerDiego Muilenburg, Colin Parsons, Jodi Coates, et al.
JAMA Surgery|May 23, 2014
Outcomes of pancreaticoduodenectomy: where should we focus our efforts on improving outcomes?Erin G Brown, Anthony Yang, Robert J Canter, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2004
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell lineMelinda M Mortenson, Michael G Schlieman, Subbulakshmi Virudachalam, et al.
Pancreas|March 1, 1996
All-trans-retinoic acid inhibits growth of human pancreatic cancer cell linesR J Bold, J Ishizuka, C M Townsend, et al.
Pageof 19